NYPOZI
Live / Registered — Registered (as of 24 Feb 2026)
What this means for you
Registered since 24 Feb 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97388041
- Registration number
- 8152232
- Mark type
- Stylized text
- Filed
- 29 Apr 2022
- Published for opposition
- 28 Mar 2023
- Registered
- 24 Feb 2026
- Attorney of record
- GABRIELLE S. ROTH
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in stimulating white blood cell production and pharmaceutical preparations for the treatment of cancer and of blood disorders and conditions, including those caused by cancer treatments
Owner
- Tanvex BioPharma, Inc., Grand Cayman, KY
- Tanvex BioPharma, Inc., Grand Cayman, KY
- Tanvex BioPharma, Inc., Grand Cayman, KY
Prosecution history
- 24 Feb 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 Feb 2026 — REGISTERED-PRINCIPAL REGISTER
- 05 Feb 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 05 Feb 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 05 Feb 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 19 Nov 2025 — USE AMENDMENT FILED
- 19 Nov 2025 — TEAS STATEMENT OF USE RECEIVED
- 06 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 May 2025 — SOU EXTENSION 4 GRANTED
- 05 May 2025 — SOU EXTENSION 4 FILED
- 05 May 2025 — SOU TEAS EXTENSION RECEIVED
- 31 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Oct 2024 — SOU EXTENSION 3 GRANTED
- 31 Oct 2024 — SOU EXTENSION 3 FILED
- 31 Oct 2024 — SOU TEAS EXTENSION RECEIVED